Corcept Therapeutics Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 12.05 M | $1.00 B | -3.85% | 11.57% |
| VANGUARD GROUP INC | 11/07/2025 | 9.54 M | $792.63 M | -1.48% | 9.16% |
| INGALLS & SNYDER LLC | 11/07/2025 | 7.70 M | $639.78 M | -0.32% | 7.39% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 6.09 M | $506.09 M | -2.83% | 5.85% |
| PARALLEL ADVISORS, LLC | 11/13/2025 | 3.87 M | $321.76 M | 0.01% | 3.72% |
| STATE STREET CORP | 11/14/2025 | 2.97 M | $246.87 M | 0.09% | 2.85% |
| FMR LLC | 11/13/2025 | 2.20 M | $183.00 M | 62.27% | 2.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.93 M | $161.53 M | 0.97% | 1.86% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.89 M | $157.28 M | -9.26% | 1.82% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.51 M | $125.26 M | 546.89% | 1.45% |
| MORGAN STANLEY | 11/14/2025 | 1.19 M | $98.65 M | -26.46% | 1.14% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 1.16 M | $96.56 M | -0.52% | 1.12% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.07 M | $88.95 M | 31.41% | 1.03% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 956.14 K | $79.46 M | 16.62% | 0.92% |
| JPMORGAN CHASE & CO | 11/26/2025 | 849.86 K | $70.63 M | 223.37% | 0.82% |
| EPOCH INVESTMENT PARTNERS, INC. | 11/13/2025 | 847.10 K | $70.40 M | 10.67% | 0.81% |
| CERITY PARTNERS LLC | 10/22/2025 | 758.43 K | $63.03 M | 1.58% | 0.73% |
| INVESCO LTD. | 11/13/2025 | 732.58 K | $60.88 M | -29.00% | 0.70% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 720.22 K | $59.86 M | 34.07% | 0.69% |
| NORTHERN TRUST CORP | 11/14/2025 | 642.33 K | $53.38 M | -1.53% | 0.62% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 601.50 K | $49.99 M | -5.83% | 0.58% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 584.10 K | $48.54 M | -13.23% | 0.56% |
| BOSTON TRUST WALDEN CORP | 10/17/2025 | 562.26 K | $46.73 M | -1.72% | 0.54% |
| UBS GROUP AG | 11/13/2025 | 549.94 K | $45.71 M | 413.77% | 0.53% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 526.60 K | $43.77 M | 9.41% | 0.51% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 521.50 K | $43.34 M | -2.61% | 0.50% |
| SYNERGY ASSET MANAGEMENT, LLC | 10/21/2025 | 506.86 K | $39.61 M | 96.08% | 0.49% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 500.06 K | $41.56 M | 2.19% | 0.48% |
| CHECKPOINT CAPITAL L.P. | 11/14/2025 | 392.33 K | $32.61 M | 14.08% | 0.38% |
| PACER ADVISORS, INC. | 10/15/2025 | 390.56 K | $32.46 M | 6,796.68% | 0.38% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 389.09 K | $32.34 M | -30.60% | 0.37% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 383.06 K | $31.84 M | 160.42% | 0.37% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 369.87 K | $30.74 M | 16.31% | 0.36% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 369.39 K | $30.70 M | -53.17% | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 365.84 K | $30.40 M | 13.70% | 0.35% |
| JUPITER ASSET MANAGEMENT LTD | 11/10/2025 | 350.93 K | $29.17 M | -41.65% | 0.34% |
| FAS WEALTH PARTNERS, INC. | 10/29/2025 | 308.32 K | $25.62 M | 1.95% | 0.30% |
| BRIDGEWATER ASSOCIATES, LP | 11/13/2025 | 305.95 K | $25.43 M | 100.00% | 0.29% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 286.80 K | $23.84 M | -4.02% | 0.28% |
| BRAUN STACEY ASSOCIATES INC | 10/21/2025 | 280.66 K | $23.33 M | -2.29% | 0.27% |
| ABRDN PLC | 11/07/2025 | 259.08 K | $21.53 M | -7.00% | 0.25% |
| BROWN CAPITAL MANAGEMENT LLC | 11/04/2025 | 240.05 K | $19.95 M | 100.00% | 0.23% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/20/2025 | 239.81 K | $20.20 M | 11.75% | 0.23% |
| EMERALD ADVISERS, LLC | 10/30/2025 | 232.45 K | $19.32 M | -3.97% | 0.22% |
| BURNEY CO/ | 10/16/2025 | 230.77 K | $19.18 M | -7.75% | 0.22% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 222.38 K | $18.48 M | -46.95% | 0.21% |
| COOKSON PEIRCE & CO INC | 11/06/2025 | 211.31 K | $17.56 M | -2.81% | 0.20% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 202.73 K | $16.85 M | -38.68% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 201.00 K | $16.71 M | 10.38% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 188.70 K | $15.68 M | -12.31% | 0.18% |
Corcept Therapeutics Incorporated institutional Ownership - FAQ's
During the previous two years, 578 institutional investors and hedge funds held shares of Corcept Therapeutics Incorporated. The most heavily invested institutionals were:
BlackRock, Inc.: 12.05 M
VANGUARD GROUP INC: 9.54 M
INGALLS & SNYDER LLC: 7.7 M
RENAISSANCE TECHNOLOGIES LLC: 6.09 M
Parallel Advisors, LLC: 3.87 M
STATE STREET CORP: 2.97 M
74.15% of Corcept Therapeutics Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 105.92 M shares in the last 24 months. This purchase volume represents approximately $9.34 B in transactions.